chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Approximately 4 to 4 1/2 hours after vaccine notice cheeks getting red, feeling flushed.  Got more and more warm to touch. No fever.  Gradually moved to high on cheekbone. Took Tylenol and went to bed for night.  At 24 hours after vaccine still continued redness, a bit of swelling under eyes and high on cheekbone.  took tylonol. At 5;30pm took Benedryl. At 8:00pm noticed and felt swelling in bottom lip.   Went to ER.  Now 48 hours after Vaccine and two 60 mg.  of Prednisone still very red, hot flushed cheeks. No more swollen lip. Taking Pepecid, Zyretc, and Benedryl. Presciption is to taper down on Prednisone 2X60, 2X50 and so on.
Vomiting 4 hours after vaccination; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non- HCP). The reporter is the patient.  A 9-years-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 09Nov2021 16:45 (Batch/Lot number: unknown) at the age of 9 years as DOSE 1, SINGLE for covid-19 immunization. Relevant medical history included: "Asthma" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VOMITING (non-serious) with onset 09Nov2021 20:45, outcome "recovering", described as "Vomiting 4 hours after vaccination". Therapeutic measures were not taken as a result of vomiting.  Additional Information: The patient had other medical history: Asthma. He had no other vaccines in 4 weeks. No treatment received for adverse event. He did not have COVID-19 prior to vaccination and was not tested for COVID-19 since the vaccination.  No follow-up attempts are possible. No further information is expected.
Pt. states that after receiving the 2nd dose of Phizer 10/11/2021, started experiencing symptoms 10/12/2021 of weakness, fatigue, chronic migraine (still continuing), warmth in and around the left breast area, eye pain (Left), and pain at the injection. Chronic Migraine and Eye (Left) pain still continuing. No noted Primary visit.
Numbness to face around nose area.; This is a spontaneous report from a non-contactable nurse (the patient). A 32-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), intramuscularly in the left arm on 30Dec2020 at 13:30 (at the age of 32-years-old) as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. On an unspecified date, the patient experienced numbness to face around nose area. The clinical outcome of numbness to face around nose area was unknown. It was also reported that since the vaccination, the patient had not been tested for COVID-19.     No follow-up attempts are possible; information about lot number cannot be obtained.
TIA stroke requiring hospitalization overnight. Symptoms were vertigo like, left sided weakness. Treatment included statin, plavix, aspirin. Not sure its related to covid vaccine but wanted it reported just in case
This spontaneous report as received from a physician refers to an 11 year old female patient. In June 2015, the patient was vaccinated with the first dose of GARDASIL (dose, route and lot number were not reported). Other suspect therapies included MENACTRA (doses, route and lot numbers were not reported). In June 2015, the patient experienced Bell's palsy. The patient sought medical attention-she had an office visit. Treatment given for adverse event included unspecified steroids. The patient recovered from adverse event on an unknown date in 2015. Relatedness between the event and the suspect products was not reported. Additional information has been requested.
A week or so after receiving the vaccine my hair started to fall out in a small patch that progressively grew in size, multiplied throughout my head and has resulted in most of my hair fallling out. I am still currently receiving corticosteroid shot treatment on the affected areas  and it has yet to resolve after over 7 months of treatment.
I went to sleep and when I woke up I noticed that my arm was hurting and I had a bad headache. Then, for the next 2 days I had a terrible headache, body aches, and I had a fever off and on.
Erythema, Edema, to (L) leg-proximetry marked to monitor reaction.
Information has been received from a physician concerning an 8 year old male with no allergies or medical history who, about 7 years ago, in approximately 1999, was vaccinated with a dose of Varivax. There was no concomitant medication. Within the past few days, on approximately 22-MAY-2006, the patient developed a mild case of chickenpox. Unspecified medical attention was sought. No diagnostic laboratory tests were performed. At the time of the report, the patient had not recovered. A product quality complaint was not involved. Additional information has been requested.
blood pressure is "off the charts" (in her words) after taking Pfizer. it is 197/96 and it is normally 127/79.
Patient was given QUADRACEL which is intended for 4-6 years old and they are 19 months old. According to the CDC, "if a dose of QUADRACEL is inadvertently administered for an earlier dose of the DTaP and/or IPV series, the dose should be counted as valid and does not need to be repeated."
16 year old male who presents with sudden onset chest pain.  Patient states that he woke up with sudden chest pain at about 3:30 a.m. this morning and later fell asleep again as the pain was better.  Around 9:30 AM he had worsening chest pain with some radiation to the left arm and his mother took him to the ED for further evaluation.   He received his 2nd dose of the Pfizer COVID-19 vaccine on 7/6/2021 (first dose June 9th).  In the subsequent days after receiving the vaccine he had a low-grade (less than 100° F) fever at home accompanied by some headache.  Beginning on Wednesday July 7th he began to take 400 mg ibuprofen every 6 to 7 hours with his last dose being at 9 p.m. last night.   Upon arrival to the ED did feel nauseous and continued to have chest pain however symptoms were relieved after receiving a dose of ibuprofen.  He has never had symptoms like this before.  He describes the chest pain as a constant dull pain that hurts slightly more with breathing.  In the ED lab work revealed an elevated troponin of 3.8 with ST elevation on EKG. Admitted to the hospital   Primary Discharge Diagnosis Acute Myocarditis /Pericarditis
redness at vaccination site within 24 hours & progressing to rash which continues  to enlarge in area (but not as reddened as initially).
After receiving  vaccine area turned red raised and warm to the touch, the next day it turned black and blue this cleared up then around 7 days later, the patient developed red bumps all over arm and body she still currently has them.
Fever; Chills; Body aches; This is a spontaneous report from a non-contactable consumer, the patient. A 43-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 25Apr2021 at 10:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to sulfa antibiotics (sulfonamide allergy). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received other medicines (unspecified) within two weeks prior to the COVID-19 vaccine. On 26Apr2021 at 00:00 the patient experienced fever, chills and body aches. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, chills and body aches was resolving at the time of this report.   No follow-up attempts are possible. No further information is expected.
bone pain/ bone pain is very severe; feeling his bones boiling; damages his stomach; sweating; headache; fever; muscle pain; This is a spontaneous report from a contactable consumer (patient). A 53-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number was not reported) via an unspecified route of administration on 30Mar2021 as a single dose for covid-19 immunization. The patient's medical history was not reported. Concomitant medication included paracetamol (TYLENOL) taken for bone pain, headache, pyrexia, hyperhidrosis, myalgia, feeling abnormal, start and stop date were not reported. The patient experienced bone pain, headache, fever, sweating, muscle pain and the bone pain was very severe leading him to feel his bones boiling on an unknown date in 2021. He reported that as a result of symptom's intensity he went to emergency service on 04Apr2021, and they prescribed Tylenol for the symptom management. He reported that Tylenol did not work well on him and damaged his stomach. During his stay in the emergency service, patient underwent lab tests and procedures which included coronavirus laboratory test and the result was negative on an unknown date in 2021. The patient called to request information about whether the symptoms experienced after the administration of first dose of the Pfizer covid-19 vaccine could occur again after the administration of second dose. The outcome of all the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Began to experience irregular heart pattern about 10 hours after vaccine administration. Restless sleep due to generalized aches/pains. At 5:00 a.m., went to restroom and experiences loss of balance, dizziness, and sweating. Subsided rather quickly once he lied back down. Took Tylenol at 6:45 a.m. Continued to experience sweating and dizziness when standing.
Swelling, redness, pain in left arm injection site. Lump on collarbone that is causing pain on left side upper chest pains and left side neck pains, as well as left side head pains
(L) arm edema and erythema within hours of injection tender to touch. No abscess or induration. Distal to injection site only present in Pneumovax site not influenza.
After first dose - fatigue, body aches, and headache. - After 2nd dose - headache, body aches, fatigue, abnormal bleeding (cycle started 4 days on the 4/15/21, lasted 7 days, stopped for 4 days, started again on 4/27/21 much heavier than the first time, iron level dropped causing extreme fatigue and headaches, lasted another 6 days. I took iron for 4 days to get my levels back up.
Pt c/o of shoulder pain that started day after flu shot. Pain gets worse when lifting. Advised pt to go to doctor - (Pain still present 11/15/13).
Pharmacist checked with patient 5-10 minutes after administration and inquired how patient was. Patient reported feeling lightheaded and was experiencing nausea with a "tingling sensation" that was moving from their arms to both arms. Patient was brought back into vaccine administration room from waiting room by pharmacist. The pharmacist laid the patient on floor and attached a blood pressure cuff. Pharmacist took blood pressure reading and monitored blood pressure with intern every five minutes as the pharmacist called 911. Patient's first blood pressure was 104/69 mmHg with pulse of 71 bpm. Consequential blood pressure readings and pulses were 132/69 with 75bpm and 129/86 with 75 bpm. Upon arrival of EMT, patient had reported having little to no tingling and was no longer feeling lightheaded or nauseous. EMT performed a work-up of the patient and ultimately informed the patient that they seemed fine and were OK to go. Patient informed the pharmacy and left of their own accord.
Patient was vaccinated at a Medical Center in January 2021. She tested for COVID-19 on Friday 3/19 for personal purposes (she is asymptomatic) and the test resulted positive on Monday 3/22/21. She confirmed that her towns health dept. has been in contact with her and that she did have a PCR test done. Her information is as follows:1st Dose: 1/4/21; Pfizer EL0140  2nd Dose: 1/25/21; Pfizer EL1284
Pt developed swollen lymph nodes in neck, headache, pain in neck and aches in joints of ankles and knees.
Pt states she gets frequent breakouts of "shingles"-about 3X/yr for the last 6 yrs.  MD recommended ZOSTAVAX.  Pt was clear of any symptoms.  Shot was administered 1/14/09.  On 1/26/09, pt dev. rash on M'D-back L thigh.  It blistered, was itchy + painful.  VALTREX was begun on 1/27 1gm + 1 D X 7 days + VICODIN on 1/28- 1  86 degrees PRN.
Patient received Moderna as 2nd vaccine instead of Pfizer. Her first covid vaccine was on 3/5/2021, received Pfizer. Presented to clinic on 12/18/21 in request of second vaccine. Moderna given @1230. Patient remained in clinic for 15 minutes: VS as followed: 98% RA RR 14 BP 130/72 T 97.2. No immediate reaction.
Clinic recommended a 5 minute wait time after receiving the vaccine. After five minutes of waiting with no symptoms I left the clinic and drove to a grocery store across town. While in the grocery store I fainted without any side effects. Woke up on my face bleeding out of my nose.
Knee pain - stiffness in AM lasting 3-4 wks given Advil doing better.
Had 2 doses and shingles came back /Suspected Vaccination failure; Shingles came back; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles.   On an unknown date, the patient received the 2nd dose of Shingrix and the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix and Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix.     Additional Information: GSK Receipt Date: 24-OCT-2022 Reporter's comment: This case was reported by the patient via interactive digital media. The reporter stated that he/she had 2 doses of Shingrix and his/her shingles had come back. It did not helped him/her. Additional supportive information: This case was considered as suspected vaccination failure as details regarding time to onset and laboratory test confirming shingles were unknown at the time of reporting. Follow-up would not possible, as no contact, details were available.
Information has been received from a registered nurse concerning a female patient who in March 2011 "sometime in March" was vaccinated with the first 0.5 ml dose of GARDASIL intramuscularly (Lot number not reported).  Concomitant therapy included DTAP (unspecified).  The nurse reported that in March 2011 "sometime in March" after received the first dose of GARDASIL intramuscularly, the patient experienced passing out, falling and hitting her head.  She was taken to an unspecified hospital, received unspecified treatment and stayed there for an unspecified duration.  The patient had been released from the hospital and was currently having speech problems and had short term memory loss.  Therapy with GARDASIL was discontinued.  At the time of the report, outcome of the patient was unknown.  It was reported that the patient was not reintroduced to the therapy.  Passing out, fall, hitting her head, speech problems and short term memory loss were considered to be disabling.  Additional information has been requested.
Injection given at 2:30pm - 9:00pm while at home patient became very pale, heart palpitations almost fainted - ready to call 911 feeling passed 10-15 minutes later - became hoarse and throat tightened up for 15 minutes then was o.k.
2 days later burning, pain and swelling of left arm/Keflex Rx. Pain up arm into shoulder and neck - cervical spine x-ray no abnormalities, ? post injection myalgia and neuralgia. Meds Rx/P.T./TENS Unit. 12/07 Neurologist - MRI cervical spine cord compression. 12/07 Cervical spine stabilization surgery - OOW extended time.  4/28/2008 MR received for ER visit 11/10/2007 with DX: Torticollis.  Pain, acute, chronic-neck, upper back.  Pt presented to ER with c/o sharp L sided neck, shoulder blade and shoulder pain. PE (+) muscle spasm and decreased ROM.  5/19/2008 MR received for DOS 12/11-14/2007 with D/C DX:  C3-C4 C4-C5 herniated disc with stenosis, radiculopathy, myelopathy. Pt had a C4 corpectomy, decompression of the spinal cord, foraminotomy, interbody fusion with allograft. 01/21/2010 Patient received a Tdap injection on 4/23/07. She began to experience pain in her shoulder and neck and was seen by our physician. Was referred to physical therapy. Doctor performed MRI with contrast with resulting surgery by doctor for bulging disc and reticulopathy to left arm. Fusion and plate were performed by doctor with expectation that she would be out of work until 12/26/07. Resulting scar was addressed by doctor. Doctor placed her on part time with hours to increase as her pain became more managable. Patient was leaving early when dictated by pain. MRI scheduled on 11/24/08 by doctor. Doctor ordered home exercises for chronic pain management and depression as there were problems regulating her medications. On 1/05./09 surgery was performed by Orthopedist and diagnosed with pocket of inflammation. Referral to Rheumatologist and to patient's PCP. Chronic pain is still a problem. 02/02/09 doctor felt that work schedule should remain restricted due to cervical pain and on 2.27/09 left shoudl arthroscopy was performed with resulting slight rotator cuff repair and clean up of inflammation. Doctor cleared her to return to work on 4/10/09 with no restiriction; however doctor still feels that work hours may need to be adjusted due to pain.
Headache; literally cant sleep; Severe allergies nasal/throat; itching skin; loss of smell; severe allergies; nausea; puking; hot/cold body temp with low grade temp; Pain in hands and feet; Pain in hands and feet; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 20Mar2021 at 07:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation and also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 10Apr2021 at 07:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included lupus, type 2 diabetes mellitus, kidney disease, Postural Orthostatic Tachycardia Syndrome (POTS), Ehlers-Danlos Syndrome (EDS) and Interstitial Cystitis (IC). The patient had unspecified allergies. The patient received unspecified medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Mar2021, the patient experienced headache, literally could not sleep, had severe allergies of nasal/throat and itching skin, loss of smell, severe allergies, nausea and puking, hot/cold body temperature with low grade temperature and pain in hands and feet. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events headache, literally could not sleep, had severe allergies of nasal/throat and itching skin, loss of smell, severe allergies, nausea and puking, hot/cold body temperature with low grade temperature and pain in hands and feet were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
patient with covid between their first and second doses of the covid vaccine; patient with covid between their first and second doses of the covid vaccine; This is a spontaneous report from a Pfizer sponsored program IBCC (Inbound Call Center for HCPs). A contactable pharmacist reported similar events for two patients. This is the first case out of 2 cases. A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231, expiration date: Apr2021, NDC#59267-1000-1), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient with Covid between the first and second doses of the Covid vaccine on an unspecified date. The reporting pharmacist wanted to know if the patients with covid between their first and second doses of the covid vaccine what their risk would be, Reportedly 2 different patient. The outcome of the events was unknown.; Sender's Comments: The association between the event lack of effect (COVID between first and second dose) with BNT162b2 can not be fully excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-2021011471 same reporter/drug/event, different patient..
The patient had transient elevated liver enzyme ( ALT) 3 days after being vaccinated. He recovers without any problems. Hew has no physical signs or symptoms.
warm, red rash at inj site. grew larger on day 2 and larger again on day 3. began to fade on day 4.
A non-serious spontaneous report of inadvertent administration of expired H1N1 was received from a registered nurse/health professional concerning an eight-year-old female. Neither relevant medical history nor concomitant medications have been reported for this patient. The original expiration date was 08-Apr-2010, which was reassigned to 29-Mar-2010. On 31-Mar-2010, the patient received the second dose of expired H1N1, Intranasal for an unknown indication. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments were not applicable and the event was considered to be resolved.
Patient presented to ER with a reported temp of 106F. Patient was given IV fluids and Tylenol, Temp taken at ER 99.6
arm is very red; is very raised in a circle about maybe a 3 inch by 4 inch area; itchy; This spontaneous case was reported by a  and describes the occurrence of VACCINATION SITE ERYTHEMA (arm is very red), VACCINATION SITE SWELLING (is very raised in a circle about maybe a 3 inch by 4 inch area) and VACCINATION SITE PRURITUS (itchy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 22-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (arm is very red), VACCINATION SITE SWELLING (is very raised in a circle about maybe a 3 inch by 4 inch area) and VACCINATION SITE PRURITUS (itchy). The patient was treated with CORTISONE at a dose of unknown. At the time of the report, VACCINATION SITE ERYTHEMA (arm is very red) and VACCINATION SITE SWELLING (is very raised in a circle about maybe a 3 inch by 4 inch area) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.